International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 4, Issue 5 | Case Report | Open Access DOI
Samir Gendy*
Consultant ENT Surgeon, Emersons Green and Devizes practiceplus group Hospitals, UK
*Correspondence to: Samir Gendy
Fulltext PDFA study was conducted to measure patients pain scores post nasal surgeries performed at both Emersons Green and Devizes Practice plus Hospital during the months of October and November 2024 Lignospan injection is commonly used in nasal surgeries as a local anaesthethic and decongestant prior to nasal surgical procedure.
Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, thereby effecting local anesthetic action.
Each lignospan cartridge is a 2.2ml solution for injection that contains 44mg of lidocaine hydrochloride and 27.5micograms of adrenaline so each 1 ml contains 20mg of lidocaine hydrochloride and 12.6micrograms of adrenaline (1:80,000) For normal healthy adults, the amount of lidocaine HCl administered should be kept below 500 mg, and in any case, should not exceed 7 mg/kg (3.2 mg/lb) of body weight) Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours LIGNOSPAN is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations Lidocaine should be used with caution in patients with severe shock or heart block. Lidocaine should also be used with caution in patients with impaired cardiovascular function. Local anaesthetic solutions containing a vasoconstrictor should be used with caution in areas of the body supplied by end arteries or having otherwise compromised blood supply. Patients with peripheral vascular disease and those with hypertensive vascular disease may exhibit exaggerated vasoconstrictor response. Ischemic injury (such as exfoliating or ulcerating lesions) or necrosis may result. Preparations containing a vasoconstrictor should be used with caution in patients during or following the administration of potent general anaesthetic agents, since cardiac arrhythmias may occur under such conditions.
Samir Gendy. Audit of Pain Scores Post Nasal Surgeries. Int Clinc Med Case Rep Jour. 2025;4(5):1-3.